LOGIN
Perineural Dexmedetomidine in Ultrasound-Guided Interscalene Block for Pain Management
February 2025
Perineural Dexmedetomidine in Ultrasound-Guided Interscalene Block for Pain Management
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Efficacy of Perineural Dexmedetomidine in Ultrasound-guided Interscalene Block on Rebound Pain after Shoulder Arthroscopy.
Clin J Pain . 2025 Feb 1;41(2):e1267.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Forty-seven patients undergoing shoulder arthroscopy were randomized to receive either an ultrasound-guided interscalene block (ISB) with 12 mL of 0.5% ropivacaine and 50 µg of dexmedetomidine (n=24) or 12 mL of 0.5% ropivacaine alone (n=23). The primary outcome was the incidence of rebound pain. Secondary outcomes included Numeric Pain Rating Scale (NRS) scores at 6, 12, 24, and 48 hours postoper...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.